Hemagglutinin-esterase (HE) is a structural protein forming short surface spikes on the Breda virus. It exhibits receptor-binding and receptor-destroying activities, mediating the de-O-acetylation of N-acetyl-9-di-O-acetylneuraminic acid—a likely receptor determinant on erythrocyte and susceptible cell surfaces. While it also hydrolyzes 5-N-acetyl-4-O-acetylneuraminic acid and N-acetyl-9-O-acetylneuraminic acid, it shows a preference for N-acetyl-9-di-O-acetylneuraminic acid. This receptor-destroying activity is crucial for viral release, preventing self-aggregation and ensuring efficient cell-to-cell spread of progeny virions. HE may function as a secondary attachment protein, complementing the primary spike protein in initiating infection. Although not strictly essential for viral infection in culture, its presence can influence pathogenicity. HE is a potential target for both humoral and cellular immune responses.
KEGG: vg:3707767
The hemagglutinin-esterase (HE) gene of Breda virus 1 (BRV-1) is a 1.25 kb gene located between the genes encoding membrane (M) and nucleocapsid (N) proteins in the bovine torovirus genome . This novel gene encodes a class I membrane protein that displays approximately 30% sequence identity with the hemagglutinin-esterases of coronaviruses and influenza C viruses . The HE gene in BRV-1 has an identical nucleotide sequence to that of BRV-2, while the 3'-most 0.5 kb portion is also present in the equine torovirus isolate Berne virus (BEV) genome as an X pseudogene .
The Breda virus HE protein is a 65 kDa N-glycosylated protein with a cleavable N-terminal signal sequence of 14 residues . Computer analysis predicts that residues 393-415 form a potential transmembrane domain . The protein contains the F-G-D-S motif, which serves as the putative catalytic site responsible for acetylesterase activity, similar to influenza C virus and coronavirus acetylesterases . As a structural protein, HE forms short surface projections approximately 6 nm in length on the virion surface, which are distinct from the larger 17-20 nm spikes formed by other viral proteins .
The HE gene can be amplified from torovirus genomic RNA using long RT-PCR methods. Researchers have successfully employed the following approach:
Viral RNA extraction from sucrose-gradient purified virus preparations or directly from clinical specimens
RT reaction using virus-specific primers designed based on conserved regions
PCR amplification with specific cycling parameters: denaturation at 99°C for 35 seconds, annealing at 67°C for 30 seconds, and elongation at 68°C for 5 minutes for 35 cycles
Analysis of amplicons by electrophoresis on 1% agarose gels
Direct sequencing of the amplified products or cloning into appropriate vectors before sequencing
This methodology has been successfully applied to amplify the approximately 1.2-1.4 kb region containing the HE gene from both bovine (BRV) and human torovirus (HTV) samples .
The Breda virus HE protein has been successfully expressed using several systems:
Baculovirus expression system: The HE genes of BRV-1 and HTV have been cloned and expressed in Sf9 insect cells using recombinant baculoviruses. The expressed proteins are cell-associated (not secreted) and can be purified using SDS-PAGE for further applications .
Mammalian cell expression: Heterologous expression of the BoTV HE gene has yielded functional 65 kDa N-glycosylated proteins displaying acetylesterase activity .
Virus vector-based expression: Recombinant coronaviruses (such as modified MHV strains) have been engineered to express torovirus HE proteins, providing insights into HE functionality in the context of viral infection .
Several complementary techniques can be used to detect and characterize HE expression:
Immunoblotting/Western blotting: Using antisera raised against HE proteins or antibodies targeting tagged versions of HE. Typically performed following SDS-PAGE on 12% resolving gels and transfer to PVDF membranes .
Indirect immunofluorescence: Utilizing antisera against HE or antibodies targeting epitope tags (such as HA) incorporated into recombinant HE proteins. This approach allows visualization of the cellular localization of HE .
Enzymatic activity assay: The acetylesterase activity of HE can be detected using in situ pararosanilin staining with α-naphthyl acetate as a substrate. This colorimetric assay enables direct visualization of functional HE .
Immunoelectron microscopy: This technique provides formal evidence for HE as a structural protein and allows visualization of HE incorporation into virions .
Hemagglutination inhibition assays: These can be used to detect functional HE protein and assess the binding of antibodies to the hemagglutinin domain .
Reverse genetics systems for toroviruses enable manipulation of the viral genome to study HE functionality:
BAC-based full-length infectious cDNA cloning: A reverse genetic system has been developed for BToV (Aichi strain) based on cloning a full-length genomic cDNA into a bacterial artificial chromosome (BAC) .
Generation of recombinant viruses with modified HE: This approach allows the creation of viruses expressing:
Targeted RNA recombination: This method has been used to generate recombinant viruses with modified HE genes in coronavirus models .
Analysis of recombinant virus properties:
In vitro growth characteristics
Plaque morphology
Cellular localization of HE
Assessment of esterase activity
Table 1: Comparative analysis of recombinant viruses with different HE expression profiles
| Virus Type | HE Expression | Esterase Activity | Surface Projections | Receptor Binding |
|---|---|---|---|---|
| rBToV-HEf | Full-length HE | Active | Present (6 nm) | Present |
| rBToV-HEs | Soluble HE | Active | Absent | Secreted |
| rBToV-HE0 | Mutant HE | Inactive | Present | Present |
| rBToV-HE- | None | None | Absent | Absent |
The substrate specificity of Breda virus HE is determined by specific structural features:
Arginine-Sia carboxylate interaction: A functionally conserved (but not structurally conserved) arginine-sialic acid carboxylate interaction is critical for binding and positioning glycosidically bound sialic acids in the catalytic pocket . This interaction is essential for efficient de-O-acetylation of sialic acids but is not required for catalysis itself nor does it affect substrate specificity .
Single-residue determinants: The distinct preference of porcine torovirus HE for 9-mono-O-acetylated over 7,9-di-O-acetylated sialic acids can be explained by a single-residue difference compared to HEs with more promiscuous specificity .
Co-evolution of esterase and lectin domains: Research suggests that the esterase and lectin pockets of HE proteins have co-evolved. The porcine torovirus HE receptor-binding site appears designed to use 9-mono-O-acetylated sialic acids while excluding di-O-acetylated forms, possibly representing an adaptation to replication in swine .
Studies using recombinant coronaviruses expressing torovirus HE proteins have provided insights into HE's role in pathogenesis:
Impact on viral tropism: The expression of HE proteins can modify tissue tropism in some viral backgrounds, but effects appear to be strain-dependent .
Neurovirulence modulation: In murine models using MHV-JHM backbone viruses expressing HE, significant increases in neurovirulence were observed. Interestingly, this enhanced virulence occurred regardless of whether the expressed HE was enzymatically active or inactive .
Viral dissemination: Viruses expressing HE (either wild-type or enzymatically inactive) in combination with specific spike proteins showed more extensive dissemination in target tissues compared to HE-negative viruses .
Survival rates: In intracranial inoculation models, mice infected with recombinant viruses expressing HE (both active and inactive forms) showed significantly lower survival rates than those infected with HE-negative viruses .
Several approaches have been used to study HE-receptor interactions:
Crystal structure analysis: Crystal structures of porcine and bovine torovirus HEs in complex with receptor analogs have provided detailed insights into the molecular basis of receptor recognition .
Structure-guided biochemical analysis: This approach has revealed critical interactions in the esterase domain that are essential for binding and positioning of glycosidically bound sialic acids .
Site-directed mutagenesis: Specific amino acid substitutions can be introduced to assess their impact on receptor binding and substrate specificity.
Receptor depletion assays: Treatment of cells with specific sialidases or chemical modifications of sialic acids can help determine the specific receptor requirements for HE binding.
Recombinant HE proteins have significant diagnostic applications:
Development of specific antisera: Purified recombinant HE proteins can be used to immunize animals (such as guinea pigs) to generate hyperimmune sera with high specificity for torovirus HE .
Immunoblot assays: Hyperimmune sera raised against recombinant HE proteins can detect a 65 kDa protein (corresponding to HE) in bovine torovirus (BTV) and human torovirus (HTV) positive samples .
Dot blot analysis: This method allows rapid screening of clinical specimens using HE-specific hyperimmune sera .
Cross-reactivity testing: Antisera raised against BRV-1 HE show cross-reactivity with HTV, and vice versa, indicating conserved epitopes between species variants .
Convalescent sera reactivity: Human convalescent sera and post-infection sera from gnotobiotic calves react with recombinant HE in immunoblot assays, confirming that HE is expressed during natural infection and represents a prominent antigen .
The acetylesterase activity of recombinant HE can be evaluated using several methods:
Colorimetric esterase assays: Using α-naphthyl acetate as a substrate, followed by pararosanilin staining to visualize enzyme activity .
Specific sialic acid substrate assays: Testing activity against defined O-acetylated sialic acid substrates to determine specificity for 7-O-acetyl, 9-O-acetyl, or 7,9-di-O-acetyl sialic acids .
Hemagglutination and hemadsorption assays: These can indirectly assess functional HE activity by measuring binding to red blood cells with appropriate sialic acid modifications.
Site-directed mutagenesis of the catalytic site: Comparison of wild-type HE with mutants containing substitutions in the F-G-D-S motif provides insight into the importance of specific residues for enzymatic activity .
When designing experiments with recombinant Breda virus HE, researchers should consider:
Expression system selection: Different expression systems (baculovirus, mammalian, bacterial) may yield proteins with varying glycosylation patterns and enzymatic activities.
Purification strategy: Since HE proteins are typically cell-associated rather than secreted, appropriate cell lysis and purification methods must be employed .
Epitope tagging considerations: The addition of epitope tags (such as HA) may affect protein detection depending on the tag position. For example, HEf/HA (full-length HE with HA tag) may be poorly detected by some anti-HA antibodies despite good detection with anti-HE antisera .
Functional assay selection: Both the hemagglutinin and esterase activities should be assessed using complementary methods to fully characterize recombinant HE function.
Storage and stability: Proper conditions for maintaining enzymatic activity during storage should be established and validated.
Several cutting-edge approaches show promise for deeper understanding of HE:
Cryo-electron microscopy: This technique can provide high-resolution structural information about HE in its native conformation on the virion surface.
Single-molecule studies: These approaches can elucidate the kinetics of HE-receptor interactions and provide insights into the dynamic aspects of binding and catalysis.
Glycan microarray technology: This platform enables comprehensive analysis of HE binding preferences across diverse sialic acid modifications.
CRISPR/Cas9-mediated genetic manipulation: This allows for precise engineering of host cells to modify sialic acid display and assess the impact on HE binding and viral infection.
Comparative genomics and phylogenetics: Analysis of HE sequences across diverse torovirus isolates can reveal evolutionary patterns and species-specific adaptations in receptor recognition.
The HE protein holds significant potential for elucidating torovirus host range:
Comparative analysis of HE specificity: The differences in substrate preferences between bovine, porcine, and human torovirus HE proteins may reflect adaptations to species-specific sialic acid distributions .
HE as a determinant of host range: Studies comparing the receptor binding preferences of HE proteins from different host species can identify molecular barriers to cross-species transmission.
Modeling HE evolution: The HE gene serves as "a showpiece example of modular evolution" , providing insights into how viruses acquire and adapt novel functions through gene capture and modification.
Recombination analysis: The presence of HE in multiple virus families (toroviruses, coronaviruses, and orthomyxoviruses) suggests complex evolutionary relationships that warrant further investigation .